|
Personal data - diagnosis
|
Personal data
| Visible name: |
Hartmut S |
| Ctry: |
Deutschland |
| State/Province: |
Schl. - Holst. |
| Year of birth: |
1952 |
| Age: |
72 |
| Occupation: |
Seemann |
| Hobbies: |
Motorboot in Spanien |
| My Website: |
|
|
Data at initial diagnosis
| Date: |
01.03.2013 |
| Age at diagnosis: |
60 |
| PSA: |
11.00 |
| Biopsied? |
Yes |
| TUR-P? |
No |
| Gleason Score: |
4 + 3 = 7b |
| TNM-Stages: |
|
| Remark: |
|
|
|
Maximum measured prostate volume
| Date: |
01.04.2013 |
| PSA: |
11.00 |
| Volume in ml or cm³: |
|
|
Postoperative pathological data
| Date: |
10.04.2013 |
| Gleason Score: |
4 + 3 = 7b |
| pTNM-classification: |
pT3b L0 V0 |
| Margins: |
R0 |
| p-L-V-P-G-Findings: |
pN0 (0/4) G3 |
| See stories of: |
22.04.2013 |
|
|
Prostate cancer treatments
** PSA level at the start of the treatment
|
| from |
to |
PSA** |
Type |
Clinic |
City |
|
10.04.13 |
17.04.13 |
11.00 |
Open surgery |
Helius Klinik |
Kiel |
|
22.02.17 |
01.03.17 |
3.33 |
DaVinci |
UNI Kiel |
Kiel |
|
21.06.17 |
28.07.17 |
2.00 |
IMRT |
|
Kiel |
|
01.08.18 |
01.10.18 |
3.41 |
other ADT |
|
|
|
13.04.21 |
13.10.21 |
17.30 |
ADT2 |
|
|
|
19.07.21 |
20.10.21 |
3.31 |
ADT1 |
|
|
|
22.10.21 |
|
0.57 |
ADT1 |
|
|
|
07.11.22 |
|
3.87 |
ADT2 |
|
|
|
03.08.23 |
|
1.57 |
ADT2 |
|
|
|
13.05.24 |
17.05.24 |
250.00 |
other RT |
RLT UNI KIEL |
Kiel |
|
15.07.24 |
|
67.00 |
other RT |
RLT UNI KIEL |
Kiel |
|
|
Drugs
NEM = Nutritional supplement
|
| from |
to |
Medication |
Quantity / unit of time |
|
10.04.13 |
01.01.15 |
Keine Medikamente |
Keine NEM |
|
23.06.15 |
04.01.16 |
Curcuma |
2 Gramm/ Tag |
|
01.08.18 |
30.08.18 |
Bicalutamid |
150 mg |
|
01.09.18 |
01.09.18 |
Bicalutamid |
50 mg |
|
02.09.18 |
01.12.18 |
Bicalutamid |
50 mg |
|
02.01.19 |
31.12.19 |
Bicalutamid |
50 mg - 100 mg |
|
01.01.20 |
01.07.20 |
Bicalutamid |
150 mg |
|
02.07.20 |
30.09.20 |
Flutamid |
750 mg |
|
02.10.20 |
04.01.21 |
Bicalutamid |
150 mg |
|
12.04.21 |
13.05.21 |
Bicalutamid |
150 mg |
|
13.04.21 |
20.10.21 |
Trenantone |
11.25 mg |
|
20.07.21 |
20.10.21 |
Trenantone |
11.25 mg |
|
11.09.21 |
31.10.21 |
Darolutamid |
600 mg |
|
01.11.21 |
|
Darolutamid |
1200 mg |
|
01.08.22 |
30.09.22 |
Darolutamid |
1200 mg |
|
01.10.22 |
20.10.22 |
Bicalutamid |
150 mg |
|
21.10.22 |
|
Darolutamid |
1200 mg |
|
07.11.22 |
|
Pamorelin LA |
11.25 mg |
|
07.02.23 |
|
Pamorelin LA |
|
|
04.05.23 |
|
Pamorelin LA |
11.25 mg |
|
01.07.23 |
|
Darolutamid |
600 mg |
|
03.08.23 |
|
Darolutamid |
1200 mg |
|
10.11.23 |
23.11.23 |
Bicalutamid |
150 mg |
|
23.11.23 |
21.02.24 |
Xtandi |
|
|
24.11.23 |
|
Trenantone |
11.25 mg |
|
24.11.23 |
|
Enzalutamit |
40 mg |
|
07.12.23 |
|
der 1. kontakt |
intern |
|
22.02.24 |
|
Abirateron |
1000 mg |
|
20.03.24 |
|
Darolutamit |
1200 mg |
|
20.05.24 |
|
Abirateron |
1000 mg |
|
24.05.24 |
|
Trenantone |
11.25 mg |
|
13.06.24 |
|
Darolutamid |
1200 mg |
|
28.08.24 |
|
Trenantone |
11.25 mg |
|
13.09.24 |
24.10.24 |
Abiraterone plus Prednisolon |
1000 mg und 10mg |
|
08.11.24 |
|
Xtandi |
160 mg |
Quantity per D / M / Y etc.
|
